COPD

Criterion

Assessment

More information

Process

1.Has information available about the updating policy.

Met

If a major piece of research is published which should be practice changing, we may consider updating our content to include this, but generally prefer evidence to have gone through an independent, high quality systematic review process.

2.Provides an indication that the shared decision aid is underpinned by evidence.

Met

Source and strength of evidence set out

3.Provides information about the levels of uncertainty around event or outcome probabilities, e.g. by giving a range or by using phases such as ‘our best estimate is.

Met

eg the size of the change was unlikely to represent a meaningful difference

4.An equality impact assessment has been carried out to identify impact on inequalities groups.

No Info

Strongly based on NICE GLs so source info subject to EQIA during development

Content

1.Provides a production or publication date.

Met

About' section dated Feb 2023

2. Provides information about country of publication.

Met

UK

3. Describes the health condition or issue for which the decision is required.

Met

Benefits of addition of ICS: inhaled corticosteroid to LABA, long-acting beta agonist on exacerbations -

4.States the decision that needs to be considered.

Met

SGL2 inhibitors for patients with T2D to prevent end stage renal disease, cardiovascular mortality and total mortality

5. Provides clear information about the potential consequences, benefits and harms of each option

Met

Lists likliehood of benefit and listing of frequency of harms eg pneumonia fractures adrenal suppression

6.Displays and frames options in a consistent, balanced and impartial way - for example, using the same sized font and neutral language

Met

Cates plots describe beneficial outcomes - harms set out in narrative form

7. Uses everyday language that is widely understood, or simpler language where necessary.

Not met (reading age over 14 for aid to be explained by HCP)

Not tested - given the technical nature of the text (particularly for medication interventions) reading age unlikley to be under 14

8. Shows that effort has been made to present quantitative information about risks, benefits, chance and uncertainty in a way that is understandable to people with low levels of numeracy

Met

Cates plots describe outcomes

 9. Is presented in a digital format that complies with accessibility standards,

Not met

Accessible design principles employed.